Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with Type 1 diabetes

被引：0

作者：

K. Hermansen

P. Fontaine

K. K. Kukolja

V. Peterkova

G. Leth

M.-A. Gall

机构：

[1] Aarhus University Hospital,Department of Endocrinology and Metabolism

[2] University Hospital,Department of Diabetology

[3] General Hospital Varaždin,Centre for Diabetes

[4] State Endocrinology Research Center,undefined

[5] Novo Nordisk,undefined

来源：

Diabetologia | 2004年 / 47卷

关键词：

Glycaemic control; Hypoglycaemia; Insulin analogues; Insulin aspart; Insulin detemir; Type 1 diabetes mellitus; Variability;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：622 / 629

页数：7

共 50 条

[1] Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with Type 1 diabetes
Hermansen, K
Fontaine, P
Kukolja, KK
Peterkova, V
Leth, G
Gall, MA
[J]. DIABETOLOGIA, 2004, 47 (04) : 622 - 629
[2] Insulin analogues (insulin detemir and insulin aspart) in comparison with traditional human insulin (NPH-insulin and short-acting human insulin) in basal bolus therapy of type 1 diabetes mellitus
Khermansen, K.
Fonten, P.
Kukolyya, K. K.
Peterkova, V. A.
Leyt, G.
Gall, M.
[J]. DIABETES MELLITUS, 2006, 9 (01): : 18 - 26
[3] Cost-effectiveness analysis of basal-bolus therapy of type 1 diabetes using insulin detemir plus insulin aspart versus NPH plus insulin aspart regimens
Valentine, WJ
Wittrup-Jensen, KU
Häuser, C
Roze, S
[J]. DIABETOLOGIA, 2005, 48 : A334 - A334
[4] Cost-effectiveness analysis of basal-bolus therapy of type 1 diabetes using insulin detemir plus insulin aspart versus NPH plus insulin aspart regimens
Valentine, WJ
Wittrup-Jensen, KU
Palmer, AJ
Roze, S
[J]. DIABETES, 2005, 54 : A609 - A609
[5] Insulin detemir and insulin aspart:: a promising basal-bolus regimen for type 2 diabetes
Raslová, K
Bogoev, M
Raz, I
Leth, G
Gall, MA
Hancu, N
[J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2004, 66 (02) : 193 - 201
[6] A comparison of the cost-effectiveness of basal-bolus therapy of Type 1 diabetes using insulin detemir plus insulin aspart versus human insulin-based regimens
Palmer, AJ
Roze, S
Valentine, WJ
Smith, IC
Wittrup-Jensen, K
[J]. DIABETOLOGIA, 2004, 47 : A344 - A344
[7] Insulin aspart compared to regular insulin and insulin lispro in basal bolus therapy with NPH to treat pediatric patients with type 1 diabetes mellitus
Arslanian, S
Foster, C
Wright, NM
Stender, S
Hales, P
Hale, D
[J]. DIABETOLOGIA, 2005, 48 : A327 - A327
[8] Comparison of insulin aspart, regular insulin, and insulin lispro in basal bolus therapy with NPH to treat pediatric patients with type 1 diabetes mellitus
Arslanian, S
Foster, C
Wright, N
Stender, S
Hu, P
Hale, P
Hale, D
[J]. DIABETES, 2005, 54 : A517 - A518
[9] Multiple mealtime administration of biphasic insulin aspart 30 versus traditional basal-bolus human insulin treatment in patients with type 1 diabetes
Chen, J. -W.
Lauritzen, T.
Bojesen, A.
Christiansen, J. S.
[J]. DIABETES OBESITY & METABOLISM, 2006, 8 (06): : 682 - 689
[10] A comparison of the cost-effectiveness for basal-bolus therapy of type 1 diabetes using insulin detemir plus insulin aspart or human insulin-based regimens
Palmer, AJ
Roze, S
Valentine, WJ
Schmidt, I
Wittrup-Jensen, KW
[J]. DIABETES, 2004, 53 : A288 - A288

← 1 2 3 4 5 →